Firefly Neuroscience, Inc. Enters Warrant Exchange Agreement

Firefly Neuroscience, Inc. has entered into a Warrants Cancellation and Exchange Agreement with certain investors. This agreement, dated December 16, 2025, involves the surrender and cancellation of existing warrants issued on June 16, 2025. In exchange, the company will issue new warrants to purchase its common stock. The original warrants consisted of options to purchase 400,000 shares at $3.50 each and another 400,000 shares at $4.00 each. The new warrants will allow the purchase of 800,000 shares at an exercise price of $0.50 per share. The company anticipates receiving approximately $400,000 in gross proceeds if all new warrants are exercised, which will be used for working capital and general corporate purposes. This transaction was conducted as a private placement under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D, with the exchange of warrants relying on Section 3(a)(9) of the Securities Act.